Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
Trump administration will fund new research on controversial psychedelic drug ibogaine
Headline from MedicalXpress ·
Newest
Federal government funds U.S. ibogaine research to treat veteran PTSD and addiction
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other serious mental illnesses. Health and Human Services Secretary Robert F. Kennedy Jr.
Health Secretary Robert F. Kennedy Jr. said his department is awarding funds to prepare for the first U.S. studies of ibogaine for post-traumatic stress disorder.
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
The Trump administration is investing $4.9 million into studying the psychedelic ibogaine as a potential treatment for PTSD and other serious mental health issues. The drug has shown potential, but it also carries risk of abnormal heart rhythms and death.
WASHINGTON -- Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
The Trump administration will funnel up to $4.9 million into supporting research into ibogaine, a psychedelic that’s drawn interest as a potential treatment for PTSD and addiction.
Veterans struggling with PTSD, substance abuse and other disorders could see expanded treatment options after the federal government approved $4.9 million for U.S.-based clinical research on ibogaine. Federal ibogaine research funding Health Secretary Robert F. Kennedy Jr.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Trump administration will fund new research on controversial psychedelic drug ibogaine | Since Then
